🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether one or two 17-week regime...
Status
Active Not Recruiting
Location
TBTC Site 26 Seattle & King County TB Control Program
Start Date
2023-11-21
Trial ID
NCT05766267
Treatments Being Tested
This is a randomized controlled clinical trial comparing treatment success ...
Status
Terminated
Location
King Dinuzulu Hospital
Start Date
2017-06-14
Trial ID
NCT03237182
Treatments Being Tested
The purpose of this study is to assess the mycobactericidal activity of the...
Status
Completed
Location
Task Applied Science, Karl Bremer Hospital
Start Date
2012-03
Trial ID
NCT01498419
Treatments Being Tested
The trial will evaluate the extended bactericidal activity of 14 consecutiv...
Status
Completed
Location
Centre for Tuberculosis Research Innovation, UCT Lung Institute
Start Date
2010-10
Trial ID
NCT01215851
Treatments Being Tested
The objective of this study is to analyze the efficacy of a new regimen usi...
Status
Recruiting
Location
Asan Medical Center
Start Date
2022-12-13
Trial ID
NCT05381194
Treatments Being Tested
This is a Phase 1, single-center, randomized, single-blind (participants ar...
Status
Completed
Location
Parexel Early Phase Clinical Unit - Los Angeles
Start Date
2024-10-01
Trial ID
NCT06649942
Treatments Being Tested
The current treatment regimen for MDR-TB has poor outcomes and costs of tre...
Status
Completed
Location
Republican Scientific and Practical Centre for Pulmonology and Tuberculosis hospital
Start Date
2020-10-20
Trial ID
NCT04207112
Treatments Being Tested
Pretomanid is being used in an antimicrobial combination regimen(s) to trea...
Status
Completed
Location
National Center for Tuberculosis and Lung Diseases
Start Date
2021-09-16
Trial ID
NCT04179500
Treatments Being Tested
Rifampicin-resistant tuberculosis (RR-TB) is characterized by a long treatm...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07126639
Treatments Being Tested
To evaluate the efficacy, safety and tolerability at 8 weeks (2-months), 52...
Status
Completed
Location
Evandro Chagas
Start Date
2018-07-30
Trial ID
NCT03338621
Treatments Being Tested